Sulforaphene, a CDK5 Inhibitor, attenuates cognitive deficits in a transgenic mouse model of Alzheimer’s disease via reducing Aβ Deposition, tau hyperphosphorylation and synaptic dysfunction-Reference-Cited by-同舟云学术

Sulforaphene, a CDK5 Inhibitor, attenuates cognitive deficits in a transgenic mouse model of Alzheimer’s disease via reducing Aβ Deposition, tau hyperphosphorylation and synaptic dysfunction

Published:2023-01 Issue: Volume:114 Page:109504
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Yang Wen,Xu Qing-Qing,Yuan Qiuju,Xian Yan-Fang,Lin Zhi-Xiu

Funder

National Natural Science Foundation of China

Natural Science Foundation of Guangdong Province

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference58 articles.

1. Alzheimer's disease;Blennow;Lancet.,2006

2. Synaptic impairment in alzheimer's disease: a dysregulated symphony;Forner;Trends Neurosci.,2017

3. AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss;Hsieh;Neuron.,2006

4. Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway;Shankar;J. Neurosci.,2007

5. Soluble oligomers of amyloid Beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake;Li;Neuron.,2009

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuronal double-stranded DNA accumulation induced by DNase II deficiency drives tau phosphorylation and neurodegeneration;Translational Neurodegeneration;2024-08-02

2. Systems genetics identifies methionine as a high risk factor for Alzheimer's disease;Frontiers in Neuroscience;2024-07-16

3. CDK5 Deficiency Does not Impair Neuronal Differentiation of Human Induced Pluripotent Stem Cells but Affects Neurite Outgrowth;Molecular Neurobiology;2024-06-28

4. Tianma-Gouteng pair ameliorates the cognitive deficits on two transgenic mouse models of Alzheimer's disease;Journal of Ethnopharmacology;2024-06

5. Targeting Abnormal Tau Phosphorylation for Alzheimer’s Therapeutics;Hormone and Metabolic Research;2024-02-13